Delivering a new drug or agent that carries gene therapy directly to the areas of the brain affected by Parkinson’s … Read More
Understanding the molecular basis of α-synuclein strain interference
Researchers have identified the protein implicated in the death of the brain cells that cause Parkinson’s: alpha-synuclein. What researchers don’t … Read More
Mapping Brain Region-Specific CHCHD2 Protein Assemblies and Uncovering its Variant Contribution to Parkinson’s Disease
In 2015, the discovery of another gene linked to Parkinson’s opened up new research avenues into the causes of the … Read More
Integrative screens to uncover novel regulators of SNCA expression in the context of Parkinson’s disease pathogenesis
A buildup of the alpha-synuclein protein in brain cells has become the hallmark of Parkinson’s. Recently, researchers have discovered that … Read More
Predicting gait problems
When Dr. Kevin Yen speaks of his desire to specialize in treating Parkinson’s and other movement disorders, he recalls a … Read More
Diagnosing mild cognitive impairment early
Before some people with Parkinson’s develop dementia, they often experience minor difficulty with thinking, memory or judgment. This state, known … Read More
Lloyd Cowin
Lloyd is an active volunteer with Parkinson Canada and has participated in several Parkinson’s research studies. Over the course of … Read More
Steven Iseman
Diagnosed with Parkinson’s in 2015, Steven has been an active member of the young-onset Parkinson’s community and in the broader … Read More
Liz Loewen (Vice-Chair)
Diagnosed with Parkinson’s in 2018, Liz brings both her lived experience as well as decades of involvement in health system … Read More